Kiran Reddy

Kiran Reddy is a board member at Uniquity Bio. Kiran Reddy joined Third Rock Ventures as a Senior Associate in 2008. He was promoted to principal in 2010, and then promoted to Associate Partner in 2013. As an Associate Partner, Kiran supports and manages various portfolio companies in addition to focusing on new company formation and due diligence. He was actively involved in the building and launch of Foundation Medicine and SAGE Therapeutics, and has been a member of the Partner Development Team. In addition, Kiran has served as a Board Observer for Alnara Pharmaceuticals, Rhythym Pharmaceuticals, and PanOptica. Prior to joining Third Rock Ventures, Kiran was a management consultant at the Lewin Group within in the biotechnology and pharmaceutical practice. Kiran holds MD and MBA degrees from Georgetown University and is a board-certified neurologist who completed his training at Massachusetts General Hospital and Brigham & Women's Hospital. He has authored several peer-reviewed scientific papers in the field of neuroimmunology and neurodegenerative diseases.